jcp conference-coverage

Conference Coverage

The State of Clinical Pathways – 2022 Survey Results

10/15/2022

Katie Herman

The Journal of Clinical Pathways’ Editor-in-Chief, Winston Wong, PharmD, presented results from the publication’s 5th annual benchmarking survey at the 2022 Oncology Clinical Pathways Congress, stating a trend in increased demand for improved...

The Journal of Clinical...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Pharmacy Benefits With Rising Costs of Cancer Care

10/15/2022

Craig Ostroff

Sibel Blau, MD, Medical Director at Northwest Medical Specialties, PLLC, and James Gelfand, President of the ERISA Industry Committee, presented at the 2022 Oncology Clinical Pathways Congress about pharmacy benefits in value-based pathways.

Sibel Blau, MD, Medical Director...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

System Challenges in Oncology Care—A Patient Perspective

10/15/2022

Craig Ostroff

Kellee Franklin, PhD, Chief Innovation Officer at Mindful Innovation Labs, strategic innovation consultant, shared her journey of her cancer diagnosis in 2013 and the challenges she faced with the system.

Kellee Franklin, PhD, Chief...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Health Equity and Care Coordination From the Patient Perspective

10/15/2022

Craig Ostroff

Deborah Collyar, President of Patient Advocates In Research, and a cancer survivor, presented at the 2022 Oncology Clinical Pathways Congress on patient perspective in cancer care for pathways and care coordination, emphasizing health equity.

Deborah Collyar, President of...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Value-Based Care and COVID-19

10/15/2022

Craig Ostroff

At the 2022 Oncology Clinical Pathways Congress, Mahek A. Shah, MD, MBA, MS, Physician Executive, Investor, Advisor and Managing Partner Harvard University and WTM Advisors; Harvard School of Public Health and Brigham Health, Ariadne Labs,...

At the 2022 Oncology Clinical...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Using Real-Time Dynamics to Enhance Clinical Pathways

10/15/2022

Craig Ostroff

Davey Daniel, MD, Chief Medical Officer, OneOncology, discussed at the 2022 Oncology Clinical Pathways Congress the need is to identify forces that are shaping pathways, and to learn how to build systems to support and enhance those pathways.

Davey Daniel, MD, Chief Medical...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Decision Support Through Structured Data

10/14/2022

Craig Ostroff

At the 2022 Oncology Clinical Pathways Congress, Mary M. Ichiuji, MD, Kaiser Permanente and National Physician Lead, Beacon Oncology, presented the development of Kaiser Permanente Beacon Oncology Module EPIC, a patient-centered,...

At the 2022 Oncology Clinical...

10/14/2022

Journal of Clinical Pathways

Conference Coverage

Can Real-World Evidence Improve Clinical Pathways?

10/14/2022

Craig Ostroff

At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.

At the 2022 Oncology Clinical...

10/14/2022

Journal of Clinical Pathways

Conference Coverage

Testing Hospital-Based Financial Toxicity Interventions at Memorial Sloan Kettering Cancer Center

10/01/2022

Marta Rybczynski

At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...

At least a quarter of patients...

10/01/2022

Journal of Clinical Pathways

Conference Coverage

Therapeutic Interchange Reduces Cost While Maintaining Quality of Care in the US Oncology Care Model

10/01/2022

Katie Herman

At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.

At the 2022 ASCO Quality Care...

10/01/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products